Aarvik Therapeutics
PrivateLast Round
Series 2
Sep 29, 2025
Total Funding Raised
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aarvik Therapeutics operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Series 2 round in September 2025.
Aarvik Therapeutics is a biotechnology company that develops novel molecules with an improved therapeutic index for oncology targets using proprietary modular antibody platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aarvik Therapeutics Comparables
Compare Aarvik Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 84% | |
| Iksuda Therapeutics | 80% | |
| Lonza Group | 77% |
For institutional investors. Book with your work email.
Aarvik Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series 2 | Sep 29, 2025 | ||||
| Seed | Aug 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 80% MoM.
For institutional investors. Book with your work email.
Aarvik Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aarvik Therapeutics's valuation, stock price, and market status.
Is Aarvik Therapeutics a public or private company?
Aarvik Therapeutics is a private company.
What is the current stock price of Aarvik Therapeutics?
Aarvik Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aarvik Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aarvik Therapeutics worth (valuation)?
Valuation information for Aarvik Therapeutics is not publicly available.
Can I buy Aarvik Therapeutics stock?
Aarvik Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aarvik Therapeutics's last funding round?
Aarvik Therapeutics's most recent funding round was Series 2 on September 29, 2025.
Who are the main investors in Aarvik Therapeutics?
Investor information for Aarvik Therapeutics is not publicly disclosed.
Will Aarvik Therapeutics IPO soon?
No public IPO plans have been announced for Aarvik Therapeutics.
How can I track Aarvik Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aarvik Therapeutics's shares on secondary markets.